United States · FDA National Drug Code directory
Naloxone Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0641-6260_531da15c-9a2c-4121-9aa5-85b079d3908b
- Product NDC
- 0641-6260
- Form
- INJECTION
- Composition / generic term
- Nalxone Hydrochloride
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220301
- Source listing expiry
- 20261231
Source-listed ingredients
- NALOXONE HYDROCHLORIDE — .4 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 25 VIAL in 1 CARTON (0641-6260-25) / 1 mL in 1 VIAL (0641-6260-01) · 0641-6260-25
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →